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Although different experimental approaches have suggested certain regulation of the mammalian
immune system by the neuroendocrine system, the precise factors involved in the process are
largely unknown. In previous reports, we demonstrated important changes in the thymic
development of chickens deprived of the major neuroendocrine centers by the removal of
embryonic prosencephalon at 33-38 hr of incubation (DCx embryos) (Herrad6n et al., 1991;
Moreno et al., 1995). In these embryos, there was a stopping of T-cell maturation that resulted
in an accumulation of the most immature T-cell subsets (CD4-CD8- cells and CD4-CD8
cells) and, accordingly, in decreased numbers of DP (CD4+CD8+) thymocytes and mature
CD3+TcRcq cells, but not CD3+TcRy6 lymphocytes. In the present work, we restore the
thymic histology as well as the percentage of distinct T-cell subsets of DCx embryos by
supplying recombinant chicken prolactin, grafting of embryonic pituitary gland, or making
cephalic chick-quail chimeras. The recovery was not, however, whole and the percentage of
CD3+TcRcq3 thymocytes did not reach the normal values observed in 17-day-old control Sham-
DCx embryos. The results are discussed on the basis of a key role for prolactin in chicken T-cell
maturation. This hormone could regulate the transition of DN (CD4-CD8-) thymocytes to the
DP (CD4+CD8+) cell compartment through its capacity for inducing IL-2 receptor expression on
the former.
Keywords: Chicken thymus, prolactin, T-cell development
INTRODUCTION
Numerous studies have emphasized the importance of
the pituitary gland for the development and matura-
tion of mammalian lymphoid organs, mainly thymus,
although the factors involved remain to be con-
clusively characterized. Snell-Bagg and Ames dwarf
strain mice, which do not contain acidophilic cells in
the pituitary gland resulting in a deficient production
of growth hormone (GH), prolactin (PRL), and other
neuroendocrine mediators, show early thymic involu-
tion (Baroni, 1967; Baroni et al., 1967; Duquesnoy,
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1972) with decreased numbers of DP (CD4+CD8+)
cells (Cross et al., 1992; Murphy et al., 1992a,
1992b). Moreover, grafting of syngeneic pituitary
glands or administration of PRL and/or GH generally
totally or partially restores the immune system
(Berczi et al., 1981; Fabris et al., 1989; Murphy et al.,
1992a; Esquifino et al., 1991), but results are
frequently contradictory. In fact, obvious difficulties
for in vivo manipulation of mammalian fetuses make
it difficult to obtain direct evidence on the mecha-
nisms that govern the establishment of such neu-
roendocrine immune relationships during ontogeny.
In chickens, an excellent experimental model for
ontogenetical studies, we reported, several years ago,
important morphological changes in the thymus of
embryos deprived of the major neuroendocrine cen-
ters including the pineal system, hypothalamus, and
pituitary gland, by early partial decapitation (DCx
embryos) (Herrad6n et al., 1991), confirming previous
data by Jankovic et al. (1978, 1981, 1982). More
recently, we have demonstrated that such changes
affect differently the distinct T-cell subsets, resulting
in an accumulation of the most immature elements
including DN (CD4-CD8-) cells and CD8CD4
cells, and an almost total disappearance of DP
(CD4+CD8+) cells and TcRcq3-expressing cells with
few modifications in the pattern of y6 T-cell differen-
tiation (Moreno et al., 1995).
Although Jankovic and co-workers attributed the
delayed development of the immune system of DCx
embryos to the profound disturbance of their neu-
roendocrine system, the factor(s) involved were not
identified and they did not carry out any substitutive
approach to recover it. In the present study, we have
used different experimental approaches to recover the
development of T-cell subsets of DCx chicken
embryos. Recombinant chicken PRL administered
onto the chorioallantoid membrane of DCx embryos
(DCx+PRL embryos) restored T-cell development
considerably but not totally. Pituitary glands from
l 1-day old embryonic chickens grafted onto the
chorioallantoid membrane of 11-day old DCx
embryos (DCx+Hyp embryos) also induced signifi-
cant, but not total, recovery of the thymic T-cell
subsets, whereas cephalic chick-quail chimeras show
an almost complete recovery of the chicken T-cell
system. Taken together, these results support a role
for PRL in the maturation of T-cell precursors during
chicken ontogeny.
RESULTS
The thymus ofDCx embryos showed a decreased size
and delayed development with a high number of
large, blast cells, enlarged connective tissue trabecu-
lae, and absence of a clear cortico-medullary demar-
cation (Figure 1B). The in situ immunohistochemical
study, however, did not demonstrate important
changes in the expression of various cell markers
specific for thymic epithelial cells, macrophages, or
interdigitating cells, although a careful morphome-
trical analysis was not carried out (for details, see
Moreno et al., 1995). On the other hand, the thymus
of DCx+PRL (Figure 1C), DCx+Hyp embryos (Fig-
ure 1D), and chimeras (Figure 1E) showed, in general,
a normal size and morphology although the two first
ones exhibited a slight increase of the medullary area
and enlarged trabeculae (Figures 1C and 1D) when
compared to the Sham-DCx embryos (Figure 1A).
According to the expression of either cell-surface
molecule recognized by the mAb CVI-His-C7, the
three experimental approaches used recovered the
thymic T cells of DCx embryos. Although again the
values recorded in both DCx+PRL and DCx+Hyp
embryos did not reach those of control, Sham-DCx
embryos (Table II). On the contrary, values in
chimeric embryos were the same as control values
except for the proportion ofCD28 positive cells found
at day 15 of incubation. Accordingly, all thymocytes,
including those of the subcapsulary cortex, which in
DCx embryos appeared unstained (Figure 2A), were
positive for the antigenic determinant recognized by
mAb CVI-His-C7 (Figure 2B). Similar results were
obtained using a battery of mAbs MUI-83, CT1, and
5-5, which seems to recognize immature thymocytes
(Table II). The proportion of positive cells of
chimeras was similar to that of control, Sham-DCx
embryos, except for CT1 positive cells at day 17 of
incubation, whereas in both DCx+PRL and DCx+HypPROLACTIN AND T-CELL DEVELOPMENT 185
embryos, although the values were always higher than
those found in DCx embryos, they did not reach
control numbers (Table II).
The percentage of immature T cells, including DN
(CD4-CD8-) cells and CD81CD4 cells, decreased
significantly at days 15 and 17 of incubation in the
three experimental groups of DCx embryos used
compared to nontreated DCx embryos, but it did not
reach the control values found in 17-day-old Sham-
DCx embryos (Table III). Accordingly, the numbers
of DP (CD4+CD8+) cells increased, without reaching
control values, in DCx+PRL and DCx+Hyp embryos
and chimeras (Table III). In contrast, although there
was a small increase in the proportion of mature
CD4-CD8
hi cells compared to the values observed in
DCx embryos, differences were not statistically
significant (Table III). The CD4 cell marker was
always co-expressed with CD8, and the CD4+CD8
T-cell population was irrelevant in all groups ana-
lyzed (Table III).
The immunostaining of thymic sections with mAb
specific either to CD4 or CD8 confirmed the cyto-
fluorometri results. In the three experimental groups,
the pattern of staining was similar and resembled that
found in control (Figure 3A). Both CD4- and CD8-
expressing cells occupied mainly all the thymic
cortex, including the subcapsulary and outer area
(Figures 3C, to 3F), which in DCx embryos appeared
unstained with a few positive cells in the medulla
(Figure 3B).
On the other hand, although the percentage of
TcRcq3-expressing cells increased in DCx+PRL and
DCx+Hyp embryos, and chimeras, compared to the
values observed in 17-day-old DCx embryos, it was
still lower than control numbers (Table IV). In
contrast, no significant differences were observed in
B
FIGURE Histological sections of thymic lobes from 17-day-old (A) Sham-DCx, (B) DCx, (C) DCx+PRL, (D) DCx+Hyp, and (E)
chimera embryos were stained according to methylene blue. Note the morphological similarities among thymi from (A) control, Sham-DCx,
and (C, D, and E), recovered embryos and the scarce development of (B) DCx-thymus. Magnification: 50.186 J. MORENO et al.
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TABLE II Proportion of CVI-His C7, 2-4, 5-5, CT1, and MUI-83 Positive Cells in Sham-DCx, DCx, DCx+PRL, DCx+Hyp embryos and
Chimeras
Day of incubation CVI-His-C7 2-4 (CD28) 5-5 CT1 MUI-83
Sham-DCx 15 84.3 _+ 10.4 91.3 _+ 1.5 60.0 5.4 76.1 4.0 70.1 _+ 5.6
17 93.0 1.6 90.8 1.0 68.6 5.1 88.7 _+ 2.9 80.7 3.1
DCx 15 67.7 4.2* 72.1 _+ 3.8** 49.7 12.3 59.3 4.6** 47.4 _+ 11.2"*
17 51.2 14.7"* 58.0 5.6** 34.2 _+ 7.8** 29.8 10.2"* 29.8 _+ 12.7"
DCx+PRL 15 ND 90.1 1.4 ND 85.6 _+ 2.1" ND
17 86.5 _+ 0.3** 84.8 _+ 4.3* 54.4 7.8* 68.5 _+ 6.1"* 58.3 _+ 5.6**
DCx+Hyp 15 70.2 7.6 77.7 1.5"* 52.9 _+ 4.9 49.9 6.0** 56.2 _+ 8.9*
17 86.7 _+ 6.4* 88.7 _+ 3.9 59.4 _+ 3.1" 69.3 _+ 7.5** 48.8 _+ 11.8"*
Chimera 15 87.9 _+ 5.6 86.4 3.4* 75.5 _+ 8.2* 61.4 9.1" 76.7 7.6
17 92.6 4.2 91.9 2.0 76.0 8.4 81.2 3.8* 77.6 3.8
ap _<_ 0.1 and p --< 0.05 significant differences to control, Sham-DCx values are marked as * and **, respectively.
FIGURE 2 Thymi of 17-old-day (A) DCx and (B) chimera
embryos stained with the mAb CVI-His-C7. Note the lack of
staining in the subcapsulary cortex of DCx embryo (arrowheads).
Magnification: 62.
the proportion of 76 positive T cells, although the
variations between each of the embryos analyzed
were considerably high (Table IV). In all groups of
embryos, the highest values occurred on day 15,
decreasing thereafter (Table IV). In parallel, the
recovery of CD3 T-cell subsets observed in the
DCx+PRL and DCx+Hyp embryos as well as in the
chimeras was also incomplete and reflected the
expression of these cell-surface molecules in TcRy6-
expressing cells (Table IV).
Endocrinological Background
Like the DCx embryos (Figures 4A to 4D), DCx+PRL
embryos showed considerable delay in the develop-PROLACTIN AND T-CELL DEVELOPMENT 187
TABLE III Percentages of DN (CD4-CD8-), CD4-/CD8l, CD4-/CD8high, DP (CD4+CD8+), and CD4+CD8 Cells in Sham-DCx, DCx,
DCx+PRL, DCx+Hyp Embryos and Chimeras
Day of incubation CD4-/8- CD4-/81ow CD4-/8high CD4+/8+ CD4+/8-
Sham-DCx 15 43.8 _+ 6.6 13.0 _+ 1.6 17.9 _+ 3.5 24.0 _+ 4.2 1.0 _+ 0.4
17 17.5 _+ 1.4 7.0 _+ 1.0 12.2 2.0 64.1 _+ 2.7 1.0 0.1
DCx 15 59.1 14.7"* 25.3 7.9** 9.0 6.4* 6.0 _+ 1.6"* 0.3 _+ 0.1
17 42.6 4.2** 34.1 6.2** 14.6 _+ 3.0 8.1 +_ 3.0** 0.5 _+ 0.2
DCx+PRL 15 33.8 5.3 17.5 _+ 0.8** 19.6 2.8 28.8 4.1 0.4 _+ 0.1
17 23.1 _+ 1.7"* 10.4 1.9" 14.0 6.0 45.9 _+ 6.6** 1.4 _+ 0.1
DCx+Hyp 15 42.8 _+ 4.9 16.2 _+ 3.7 18.1 _+ 6.6 21.7 _+ 5.6 1.6 _+ 0.6
17 26.6 3.0** 9.7 0.9* 18.7 2.0** 48.0 _+ 2.8** 1.2 _+ 0.4
Chimera 15 38.3 _+ 11.8 18.8 _+ 4.0 20.7 _+ 4.0* 20.3 _+ 2.9 1.1 0.4
17 27.0 _+ 13.3"* 11.8 _+ 0.3** 18.6 10.2 40.7 6.9** 1.6 _+ 0.7
ap --< 0.1 and p --< 0.05 significant differences to control, Sham-DCx values are marked as * and **, respectively.
ment of thyroid (Figure 5A), adrenal glands (Figure
5B) and gonads (Figures 5C and 5D). In contrast, the
development of these endocrine organs in both
pituitary gland grafted DCx embryos (Figures 6A to
6D) and chimeras (Figures 7A to 7D) was generally
similar to that exhibited by control, Sham-DCx
embryos (Figures 8A to 8D), although in the first
ones, they showed a slight delay.
RIA analysis revealed a lack of GH in all the five
groups of chicken embryos at both 15 and 17 days of
FIGURE 3 CD8-positive cells in the thymus of 17-day-old (A) Sham-DCx, (B) DCx, (C) DCx+PRL, (D) DCx+Hyp, and (E) chimera
embryos. An enlarged unstained subcapsulary cortex (arrowheads) that contains CD8 negative cells appears in the (B) DCx thymus.
Magnification: 62.188 J. MORENO et al.
TABLE IV Percentages of CD3-Positive Cells, TcRcq3 Cells, and TcRy6 Cells in Sham-DCx, DCx+PRL, and DCx+Hyp Embryos and
Chimeras
Day of incubation CD3 TcRcq3 TcRy6
Sham-DCx 15 36.3 _+ 4.2 8.4 2.0 22.7 _+ 2.3
17 44.8 9.2 21.8 _+ 1.4 12.3 _+ 2.5
DCx 15 22.0 _
1.4"* 4.5 _+ 0.7** 18.3 _+ 1.0"*
17 19.0 _+ 5.4** 7.4 _+ 3.2** 15.3 5.7
DCx+PRL 15 32.8 _+ 3.1 5.0 _+ 0.4 22.6 2.0
17 24.1 1.5"* 13.7 _+ 2.5** 9.1 _+ 2.5
DCx+Hyp 15 20.8 1.2"* 2.9 0.6** 15.2 3.1"*
17 32.6 12.0 12.7 0.8** 11.8 _+ 0.9
Chimera 15 32.9 6.9 3.6 _+ 0.9* 30.7 3.6**
17 29.9 2.7 11.4 5.4** 16.8 _+ 6.4
ap __< 0.1 and p --< 0.05 significant differences to control, Sham-DCx values are marked as and **, respectively.
FIGURE 4 (A) Thyroid gland, (B) adrenal gland, (C) ovary, and
(D) testis of a 17-day-old DCx embryo were embedded in plastic
resin for light microscopy examination. Note (A) the lack of fully
developed thyroid follicles devoid of colloidal fluid, the few
numbers of both chromaffin cells (arrows), and interrenal cells
(arrowheads) of the (B) adrenal gland, the scarcely developed
intertitial cells (arrows) of the (C) ovary and (D) the lack of well-
developed seminiferous tubules in the testis. Magnification:
175.
incubation (data not shown). On the other hand,
relative plasma levels of PRL were similar in
FIGURE 5 (A) Thyroid gland, (B) adrenal gland, (C) ovary, and
(D) testis of a 17-day-old DCx+PRL embryo were embedded in
plastic resin for light microscopy examination. The prolactin
treatment does not recover the normal histology of endocrine
organs, which resembles that found in the DCx embryos (Figure 4).
Magnification: 175.
chimeras and Sham-DCx embryos, but significantly
lower in both DCx+PRL and DCx+Hyp embryos
(Figure 9). No PRL was found in the plasma of DCx
embryos.PROLACTIN AND T-CELL DEVELOPMENT 189
FIGURE 6 (A) Thyroid gland, (B) adrenal gland, (C) ovary, and
(D) testis of a 17-day-old DCx+Hyp embryo were embedded in
plastic resin for light microscopy examination. The organs
resemble generally those found in control Sham-DCx embryos
(Figure 8), but the histological recovery is not fully achieved.
Magnification: 175.
FIGURE 7 (A) Thyroid gland, (B) adrenal gland, (C) ovary, and
(D) testis of a 17-day-old chimera were embedded in plastic resin
for light microscopy examination. The organs exhibit the same
histological features than those observed in the control Sham-DCx
embryos (Figure 8). Magnification: 175.
DISCUSSION
We (Herrad6n et al., 1991; Moreno, 1994; Moreno et
al., 1995) and other authors (Jankovic et al., 1978,
1981, 1982) have demonstrated profound changes in
the thymus development of chicken embryos deprived
of the major neuroendocrine centers by early partial
decapitation (DCx embryos). In this model, the
TcRoz/3-expressing T cells seem to be specially
affected, as well as the percentage of DP
(CD4+CD8+), DN (CD4-CD8-), and CD81CD4
cells, whereas y6 T cells and CD8hiCD4- cells show
few changes. Although profound disturbance of the
developing neuroendocrine system has been empha-
sized to be involved in these changes (Jankovic et al.,
1981, 1982), precise causative agents remain unclear.
Our current results demonstrate that the treatment
of DCx embryos with a single dose of 25 ng per day
of recombinant chicken PRL from day 10 of incuba-
tion to the day of sacrifice induces an important, but
not total, recovery of the T-cell system. In mammals,
numerous data indirectly support a role for GH and
PRL in the normal development of the immune
system, mainly the thymus. However, in embryonic
chickens, as shown by our own results, circulating
levels of GH are not detected before day 17 of
incubation (Harvey et al., 1979), although somato-
trophic cells are present in the 12-day-old embryonic
pituitary gland; it is thus impossible to assign a role
for this hormone in the changes observed in the
thymus of DCx embryos. In contrast, PRL appears in
the chicken embryos at day 11 of incubation (Harvey
et al., 1979), and increasing evidence supports its
immunoregulatory influence on the adult immune
system (Gala, 1991; Hooghe et al., 1993) as well as a
certain relevance for thymic maturation (Hiestand et
al., 1986). Thus, both Snell-Begg and Ames dwarf
mice, which show important immune deficiencies,190 J. MORENO et al.
FIGURE 8 (A) Thyroid gland, (B) adrenal gland, (C) ovary, and
(D) testis of a 17-day-old Sham-DCx embryo were embedded in
plastic resin for light microscopy examination. Note the well-
developed (A) thyroidal follicles, the chromaffin cells (arrows), and
the cords of interrenal tissue (arrowheads) in the (B) adrenal gland,
the groups of intersticial cells (arrows) in the (C) ovary, and the
seminiferous tubules in the (D) testis (arrows). Magnification: (A)
125; (B, C, and D) 175.
exhibit low levels of PRL (Barkley et al., 1982), but,
in contrast, dwarf children with normal values of the
hormone do not present relevant immunological
alterations (Gala, 1991). Moreover, Cincotta et al.
(1995) reported recently that properly timed PRL
administration enhances total murine thymus cell
number. In agreement, our current results demonstrate
that PRL supply recovers T-cell system of DCx
embryos in a similar way to that observed in
DCx+Hyp embryos grafted with an embryonic pitui-
tary gland, although in this later experimental condi-
tion, the endocrine organs (i.e., thyroid, adrenal
glands, and gonads) exhibit an almost normal his-
tology. Accordingly, although other endocrine factors
(see later) could be involved, PRL seems to be key
factor for recovery of the T-cell system of DCx
embryonic chickens.
On the other hand, even low levels of PRL seem be
sufficient to bring about this recovery, confirming the
previous evidence that a slight, even temporary, rise
in PRL concentration has important effects on the
mammalian immune system (Meltzer et al., 1983;
Rovensky et al., 1991). In DCx+PRL embryos, the
rapid metabolization of PRL, as previously shown in
mice (Cross et al., 1992), may account for the low
levels of hormone found. In addition, in chickens,
unlike mammals, the hypothalamus stimulates both
production and release of PRL (Kragt and Meites,
1965; E1 Halawani et al., 1984). Also the numbers of
histologically identifiable PRL-producing cells in the
grafted pituitary glands were very low (data not
shown). There is, therefore, a slight increase of PRL
levels in 15-day-old DCx+Hyp embryos, but the
absence of hypothalamus impedes the elevation of
circulating PRL, which in normal embryos occurs on
days 15-17 of incubation (Harvey et al., 1979).
In the DCx embryos, there is some slowing of the
maturation of the first wave of T-cell precursors,
which reaches the thymus on days 6.5-8 of incuba-
tion, and complete impediment of the second wave,
which colonizes the 12-14-day-old thymus (Moreno
et al., 1995). This results in a gradual accumulation of
the most immature T-cell subsets, including DN
(CD4-CD8-) and CD81CD4 cells, and, accord-
ingly, decreased numbers of DP (CD4+CD8+) and
mature CD3+TcRcq3
hi thymocytes. The recovery
observed in our current results suggests, therefore,
that PRL could be providing direct or indirect signals
for the maturation ofDN thymocytes.
In mammals, several authors have claimed a direct
role for PRL in the intrathymic T-cell maturation
(Pierpaoli et al., 1976; Singh and Owen, 1976; Russell
et al., 1988; Gala, 1991), with both DN (CD4-CD8-)
and DP (CD4+CD8+) thymocytes as the main target
cells for PRL (Cross et al., 1992; Murphy et al.,
1992a, 1992b). However, other immunocompetent
cell types, including peripheral CD8 or CD4 cells
and B lymphocytes, also respond to the hormone
(Russell et al., 1988; Mukherjee et al., 1990; Gagner-
ault et al., 1993; Viselli and Mastro 1993). Aged rats,
which accumulate DN (CD4-CD8-) cells resulting in
a defect in DP thymocytes, almost entirely recoverPROLACTIN AND T-CELL DEVELOPMENT 191
their DP (CD4+CD8+) cell compartment after implan-
tation of GH3 cells, which produce both GH and PRL
(Li et al., 1992). DW/J dwarf mice exhibit a DP
thymocytes deficiency, a consequence of a slight
increase of mature CD4+CD8 cells and the migration
of DP (CD4+CD8+) cells to periphery, but, princi-
pally, because of the accumulation of immature DN
(CD4-CD8-) cells (Murphy et al., 1992a). Because
GH administration only slightly corrects the defect,
the authors conclude that the PRL plays a role in the
observed alterations. This view is also supported by
results that demonstrate a remarkable recovery in the
number of DP (CD4+CD8+) thymocytes of dwarf
mice, when the time of weaning is considerably
delayed (Cross et al., 1992), indirectly suggesting that
maternal PRL is the causative agent for this improve-
ment.
In general, PRL seems to be involved in cell
proliferation and maturation of immune responses
(Bhat et al., 1983; Skwarlo-Sonta, 1990; Berczi et al.,
1991), acting through the IL-2/IL-2R complex
(Mukherjee et al., 1990; Matera et al., 1991; Viselli et
al., 1991) and the expression of specific PRL
receptors on different lymphoid-cell subsets (Russell
100 % DAY 15 DAY 17 %
100
FIGURE 9 Relative levels of plasma PRL in DCx, DCx + PRL, and DCx + Hyp embryos and chimeras to those found in Sham-DCx
embryos at 15 and 17 days of incubation.192 J. MORENO et al.
et al., 1985; Bellusi et al., 1987; Pellegrini et al.,
1992; Koh and Phillips, 1993; Viselli and Mastro,
1993). Although, there is not information available on
the condition in chickens, indirect evidence suggests a
similar situation. PRL affects the proliferative
response of chicken thymocytes and splenocytes,
although the cell subsets involved have not been
identified (Skwarlo-Sonta, 1990). In addition, both
chicken and turkey PRL induces in vitro proliferation
of rat Nb2 cells (Soares and Proudman, 1991).
We can speculate, therefore, that PRL could
mediate chicken T-cell differentiation by regulating
the expression of IL-2 receptors on DN (CD4-CD8-)
cells. Thus, in the absence of hormone, as occurs in
DCx embryos, the number of DN (CD4-CD8) IL-
2R+ thymocytes decreases to stop the maturation of
T-cell precursors. Why, however, does the T-cell
system in the three experimental models used not
totally recover, including the chick-quail chimeras?.
Because, principally in DCx+Hyp and, obviously, in
DCx+PRL embryos, recovery of the neuroendocrine
system is incomplete, other neuroendocrine factors,
apart from PRL, might be involved in the regulation
of chicken T-cell differentiation. Thyroid hormones
have important effects on chicken immune system
(see review in Marsh and Erf, 1996) although results
are frequently controversial and a target lymphoid cell
for thyroxine remains to be clearly identified. Never-
theless, Glick (1984) indicated that the administration
of propylthiouracyl, an inhibitor of thyroxine synthe-
sis, induced an imbalance in the thymic cortex/
medulla ratio, similar to that found in DCx embryos
(Moreno et al., 1995). On the other hand, the
important recovery observed in 17-day-old embryos
in the three experimental models used also suggests
that the length of treatment is insufficient for full
recovery. Unfortunately, the drastic experimental
procedure used made it impossible to obtain DCx,
DCx+PRL, or DCx+Hyp embryos later than 17-18
days of incubation. Accordingly, research in progress
is analyzing the recovery of 10-day-old embryonic
thymus organ cultures provided with PRL, thyroxine,
or both hormones, so that we can confirm or reject our
hypothesis.
MATERIALS AND METHODS
Embryos and Surgical Procedure
Fertile eggs of White Leghorn chickens were pur-
chased from a local supplier and hatched under
standard conditions in a forced-draft incubator at 38 +
IC and 80% humidity. The embryo age was
estimated by the duration of incubation and a
minimum of four embryos of studied stages and
methodological procedure were used.
At 33-38 hr (stage 10 of Hamburger and Hamilton),
chicken embryos were partially decapitated (DCx
embryos) according to Fugo’s method (Fugo, 1940).
Briefly, a window was opened in the shell and a cross-
section was made through the midportion of the
embryonic prosencephalon. The free anterior portion
of the head was then extirpated by suction. The
window was closed with adhesive tape and the egg
returned to the incubator until sacrifice. Embryos
33-38 hr old, whose shells were opened and closed,
served as control, sham-decapitated (Sham-DCx)
animals.
For the recovery of DCx embryos, three different
experimental approaches were used. A group of DCx
embryos was treated by dipping on the chorioallan-
toid membrane a single dose/day of 25 ng of chicken
prolactin (kindly provided by A. F. Parlow, Pituitary
Hormones and Antisera Center, Torrance, CA)
diluted in 100/xl of PBS from day 10 of incubation to
the day of sacrifice (DCx+PRL embryos). In another
group, the pituitary glands from 11-day-old embry-
onic chickens were grafted onto the chorioallantoid
membrane of 11-day-old DCx embryos. A third group
of animals consisted of cephalic chick-quail chimeras
made by replacing the anterior midportion of the
prosencephalon of a 33-38-hr chicken embryo with
the same portion of a 30-33-hr quail embryo brain
(chimera). The success of the different surgical
procedures was achieved by routine histological
sectioning either of the head or the grafted pituitary
gland.
All embryos were inspected daily for viability and
sacrificed on days 15 and 17 of incubation. Blood
samples were taken from the chorioallantoid mem-PROLACTIN AND T-CELL DEVELOPMENT 193
brane and the plasma saved for measurement of both
PRL and GH levels. Thymic lobes were aseptically
removed and processed either for immunohistochem-
ical or flow cytometrical analysis (see later). In order
to evaluate the endocrinological background of differ-
ent groups of studied embryos, thyroid, adrenal
glands, and gonads were also fixed in Bouin’s fixative
and embedded in plastic resin for light microscopy
examination.
Immunohistochemistry
Thymic lobes aseptically removed were snap frozen
in liquid nitrogen and stored at -80C until use.
Cryosections of 8 /zm were fixed in acetone for 10
min and dried overnight. Endogenous peroxidase was
blocked with 1% H202 in methanol. After washing in
PBS, the sections were incubated for 1 hr with mAbs,
CVI-His-C7 (pan-leucocytes), CT4 (anti-CD4), or
CT8 (anti-CDS) (Table I) and a rabbit anti-mouse Ig
conjugated to horseradish peroxidase (DAKO-Immu-
noglobulins, Glostrup, Denmark) diluted 1:40 in PBS
for hr. The peroxidase was revealed using 0.05%
3,3’ diaminobenzidine (Sigma Co., St. Louis) as
chromogen and diluted in PBS plus 0.01% H202.
Sections were counterstained with methylene blue,
gradually dehydrated with graded alcohol and
mounted in DePex. Negativ,e controls were carried out
on successive sections that received only the second
antibody, whereas in situ immunostained thymic
sections from 2-week-old chickens were used as
positive controls. Histological sections were photo-
graphed with a Labophot (Nikon) light microscope
fitted with Agfapan APX 100 film (Agfa, Leverkusen,
Germany).
Flow Cytometry
Thymic cells prepared by gently pressing through a
steel mesh were suspended in PBS containing 2%
FCS and 0.1% NaN3 (pH 7.2). For one-color analysis,
0.5 )< 106 cells were incubated with the specific mAbs
listed in Table I for 30 min and, after PBS washing,
with FITC-conjugated rabbit anti-mouse Ig (DAKO-
Immunoglobulins, Glostrup, Denmark). For two-color
analysis, one more incubation was achieved with PE-
conjugated CT8 mAb. Relative immunofluorescence
intensities were measured by flow cytometry with a
FACScan (Becton-Dickinson, San Jos6, CA). FACS-
can plus and PC-lysis softwares were used for
analysis of the results.
Radioimmunoassays
Plasma PRL and GH concentrations were measured in
75-/zl aliquots by homologous double antibody RIA
with chicken hormones and specific antibodies, kindly
supplied by Dr. A. F. Parlow (Pituitary Hormone and
Antisera Center, Harbor UCLA Medical Center,
Torrance, CA). The average plasma PRL and GH
values are reported in terms of chicken PRL and GH
reference preparations AFP-103228B and AFP-
9020C, respectively. Samples were run in a single
assay to eliminate interassay variance. The intrassay
coefficient of variation was 6%.
Statistics
In the tables, each datum represents the mean value +
standard errors of percentages of positive cells of at
least three different experiments. Significant differ-
ences were evaluated by Student’s test and differ-
ences ofp -< 0.1 orp -< 0.05 with control (Sham-DCx
embryos) are marked.
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